National Health Investors, Inc. Financial Ratios — NHI Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	599.96	503.59	599.18	- -	- -	- -	- -	5.65	5.44	5.31
Return on Assets (%)	14.9	14.12	9.82	5.91	7.23	6.68	6.44	5.83	5.54	6.01	3.75	2.48	5.43	5.41	5.25
Return on Capital (%)	99.88	44.1	24.89	15.95	- -	17.79	17.05	15.94	15.52	15.92	11.98	4.7	5.4	5.29	5.13
Return on Invested Capital (%)	11.32	10.08	8.09	7.73	- -	7.99	8.18	7.9	7.81	7.52	6.4	5.11	7.37	7.63	7.28
Gross Margin (%)	100	99.17	99.59	99.66	99.57	99.59	100	100	98.18	97.1	96.1	96.48	96.4	96.67	97.08
EBITDA Margin (%)	90.61	92.71	91.75	95.88	96.29	96.92	95.09	93.5	93.32	92.57	89.06	73.2	77.69	77.55	72.29
Operating Margin (%)	75.6	74.17	74.01	72.96	71.57	71.53	70.99	69.29	69.17	67.58	62.02	47.72	55.81	56.24	50.74
Incremental Operating Margin (%)	70	61.64	73.4	70.89	66.77	71.1	66.51	39.56	67.69	33.31	116.34	255.77	109.81	65.19	5.17
Pretax Margin (%)	83.37	78.05	67.58	58.06	65.35	61.77	57.19	52.39	50.44	55.68	37.5	23.51	42.02	40.77	37.48
Profit Margin (%)	96.89	97.23	90.12	57.24	65.02	60.99	57.19	52.39	50.45	55.62	37.43	23.87	42.41	41.17	37.85
Net Income to Common Margin (%)	96.89	97.23	90.12	57.24	65.02	60.99	57.19	52.39	50.45	55.62	37.43	23.87	42.41	41.17	37.85
Effective Tax Rate (%)	- -	- -	0.16	0.01	- -	0.49	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	97.24	108.11	105.77	96.32	82.14	89.87	96.03	107.17	112.03	104.9	163.11	250.42	117.38	115.68	121.74
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	60.77	19.99	-42.93	- -	- -	- -	- -	-0.98	-0.85	-1.15

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	195	267	640	884	936	1,137	1,167	1,292	1,451	1,510	1,243	1,148	1,135	1,146	1,164
ST Debt	97	64	- -	- -	- -	- -	- -	- -	- -	- -	- -	42	245	331	204
LT Debt	97	203	640	884	936	1,137	1,167	1,292	1,451	1,510	1,243	1,106	890	815	960
Total Debt/EBITDA	2.56	3.09	5.92	5.2	4.24	4.72	4.4	4.69	4.89	4.9	4.67	5.63	4.57	4.41	4.29
Net Debt/EBITDA	2.36	2.98	5.6	5.05	4.09	4.61	4.31	4.64	4.84	4.73	4.53	5.54	4.48	4.32	4.21
Total Debt/EBIT	3.07	3.86	7.34	6.83	5.71	6.4	5.9	6.33	6.6	6.71	6.71	8.64	6.36	6.08	6.11
Net Debt/EBIT	2.82	3.73	6.95	6.64	5.5	6.25	5.78	6.26	6.52	6.47	6.51	8.5	6.23	5.95	6
EBITDA to Interest Expense	28.62	27.27	12.62	7.3	6.44	6.08	6.23	6.02	5.55	6.22	5.53	4.8	4.48	4.63	5.03
EBITDA-CapEx/Interest Expense	0.03	27.27	12.62	7.3	6.44	6.08	6.23	6.02	5.55	6.22	5.53	4.8	4.41	4.56	5.03
EBIT to Interest Expense	23.88	21.82	10.18	5.56	4.79	4.49	4.65	4.46	4.11	4.54	3.85	3.13	3.22	3.36	3.53
Interest Expense	3	3	9	23	34	40	43	46	54	50	48	42	56	56	54
Common Equity/Total Assets	-5.07	-2.58	0.23	-0.01	0.95	1.26	1.3	0.67	-0.16	-0.69	-2.96	92.99	99.15	99.65	98.23
Long-Term Debt/Equity (%)	21.94	43.43	82.33	84.23	81.9	94.02	88.25	92.99	96.85	99.14	81.93	85.7	69.86	58.83	62.33
Long-Term Debt/Capital (%)	58.89	78.2	97.86	98.9	96.95	97.41	97.25	98.59	100.29	100.72	106.35	31.6	24.57	21.61	24.42
Long-Term Debt/Total Assets (%)	16.79	28.79	43.95	44.6	43.86	47.32	45.83	46.98	47.7	48.39	43.78	44.09	35.77	31.17	34.32
Total Debt/Equity (%)	43.88	57.1	82.33	84.23	81.9	94.02	88.25	92.99	96.85	99.14	81.93	88.96	89.09	82.74	75.58
Total Debt/Capital (%)	117.78	102.83	97.86	98.9	96.95	97.41	97.25	98.59	100.29	100.72	106.35	32.8	31.33	30.4	29.62
Total Debt/Total Assets (%)	33.58	37.86	43.95	44.6	43.86	47.32	45.83	46.98	47.7	48.39	43.78	45.76	45.61	43.84	41.61
Net Debt to Equity	40.3	55.14	77.95	81.86	78.88	91.88	86.41	91.89	95.79	95.6	79.47	87.47	87.34	80.98	74.3
Net Debt/Capital (%)	119.67	102.93	94.28	96.47	94.67	95.56	95.46	97.77	99.56	100.01	106.56	32.42	30.91	29.95	29.26
EBITDA	76	87	108	170	220	241	265	275	297	308	266	204	248	260	272
EBITDA-CapEx	- -	87	108	170	220	241	265	275	297	308	266	204	245	256	272
Operating Income (Loss)	63	69	87	130	164	178	198	204	220	225	185	133	178	188	191

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.22	0.3	0.31	0.07	0.24	0.08	0.05	0.07	0.06	0.49	0.53	0.17	0.07	0.06	0.07
Current Ratio	1.05	3.59	2.57	2.32	3.84	3.88	4.42	5.48	5.1	5.1	7.34	3.42	1.16	0.96	1.07
Quick Ratio	0.91	3.54	2.57	2.32	3.82	3.88	4.34	5.4	4.79	5.07	6.36	3.01	1.13	0.95	1.05
CFO/Avg Current Liab	1.05	1.1	3.13	3.08	3.27	3.16	3.49	3.31	2.99	2.57	2.67	2.03	0.85	0.56	0.66
Common Equity/Total Assets	-5.07	-2.58	0.23	-0.01	0.95	1.26	1.3	0.67	-0.16	-0.69	-2.96	92.99	99.15	99.65	98.23
Long-Term Debt/Equity (%)	21.94	43.43	82.33	84.23	81.9	94.02	88.25	92.99	96.85	99.14	81.93	85.7	69.86	58.83	62.33
Long-Term Debt/Capital (%)	58.89	78.2	97.86	98.9	96.95	97.41	97.25	98.59	100.29	100.72	106.35	31.6	24.57	21.61	24.42
Long-Term Debt/Total Assets (%)	16.79	28.79	43.95	44.6	43.86	47.32	45.83	46.98	47.7	48.39	43.78	44.09	35.77	31.17	34.32
Total Debt/Equity (%)	43.88	57.1	82.33	84.23	81.9	94.02	88.25	92.99	96.85	99.14	81.93	88.96	89.09	82.74	75.58
Total Debt/Capital (%)	117.78	102.83	97.86	98.9	96.95	97.41	97.25	98.59	100.29	100.72	106.35	32.8	31.33	30.4	29.62
Total Debt/Total Assets (%)	33.58	37.86	43.95	44.6	43.86	47.32	45.83	46.98	47.7	48.39	43.78	45.76	45.61	43.84	41.61
CFO/Total Liabilities	56.48	36.26	15.35	13.52	16.6	14.79	16.19	15.27	15.61	14.53	15.95	15.22	15.19	16.9	18.82
CFO/CapEx	1.01	- -	- -	- -	- -	- -	- -	- -	- -	1,469.29	3,294.67	- -	49.28	51.06	- -
Altman's Z-Score	5.82	4.52	1.74	1.84	1.85	1.9	1.99	1.89	1.87	1.63	1.66	2.87	2.97	3.24	3.45

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	18.25	8.15	6.66	5.9	4.49	3.43	3.07	2.78	3.16	3.55	3.02	3.07	3.73	3.66	4.2
Days Sales Outstanding	20	44.77	54.8	61.86	81.31	106.33	118.88	131.19	115.47	102.85	120.79	118.91	97.85	99.77	87
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	0.22	0.08	0.05	0.05	0.05	- -	- -	0.25	0.37	0.48	0.4	0.38	0.31	0.27
Accounts Payable Turnover Days	- -	1,693.39	4,368.78	7,157.92	6,645.04	7,419.56	- -	- -	1,454.3	973.7	758.51	915.22	954.41	1,177.89	1,354.23
Cash Conversion Cycle	- -	-1,648.62	-4,313.98	-7,096.06	-6,563.72	-7,313.22	- -	- -	-1,338.83	-870.85	-637.72	-796.31	-856.56	-1,078.12	-1,267.23
Inventory to Cash Days	- -	44.77	54.8	61.86	81.31	106.33	- -	- -	115.47	102.85	120.79	118.91	97.85	99.77	87
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	1,219	1,572	1,591	2,335	2,289	2,894	3,083	3,168	3,538	3,092	2,627	2,338	2,423	3,038	3,580
- Cash & Cash Equivalents	16	9	11	3	13	5	3	5	5	43	37	19	22	24	20
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	11	11	10	9	- -	- -	- -	1	11	10	20	20	19	18
+ Total Debt	195	267	640	884	936	1,137	1,167	1,292	1,451	1,510	1,243	1,148	1,135	1,146	1,164
Enterprise Value	1,386	1,841	2,230	3,226	3,221	4,026	4,246	4,456	4,984	4,569	3,843	3,486	3,556	4,179	4,742
Total Capital	165	260	654	894	965	1,168	1,200	1,311	1,447	1,499	1,169	3,499	3,622	3,770	3,930
Total Debt/Capital (%)	117.78	102.83	97.86	98.9	96.95	97.41	97.25	98.59	100.29	100.72	106.35	32.8	31.33	30.4	29.62
Total Debt / EV	0.14	0.15	0.29	0.27	0.29	0.28	0.27	0.29	0.29	0.33	0.32	0.33	0.32	0.27	0.25
EV/Sales	16.56	19.73	18.93	18.17	14.07	16.21	15.24	15.13	15.67	13.73	12.86	12.53	11.12	12.47	12.63
EV/EBITDA	18.27	21.28	20.63	18.95	14.61	16.72	16.02	16.18	16.79	14.83	14.44	17.12	14.31	16.08	17.47
EV/EBIT	21.9	26.6	25.58	24.91	19.65	22.65	21.47	21.83	22.65	20.31	20.74	26.26	19.92	22.17	24.88
EV/Cash Flow to Firm	17.44	20.59	19.78	21.59	16.2	18.64	17.65	17.57	16.93	16.22	14.84	15.3	14.82	15.84	16.32
EV/Free Cash Flow to Firm	8.93	20.59	19.78	21.59	16.2	18.64	17.65	17.57	16.93	16.21	14.83	15.3	14.59	15.6	16.32
Diluted Market Cap	1,222	1,574	1,593	2,338	2,291	2,904	3,102	3,180	3,561	3,092	2,628	2,339	2,423	3,056	3,593
Diluted Enterprise Value	1,401	1,843	2,232	3,229	3,223	4,037	4,266	4,467	5,007	4,569	3,843	3,487	3,556	4,197	4,756
EV per Share	50.02	66.2	78.64	96.66	85.64	103.2	103.84	106.24	114.8	102.22	84.06	77.86	81.96	95.31	101.17
TTM Sales	84	93	118	178	229	248	279	295	318	333	299	278	320	335	376
TTM EBITDA	76	87	108	170	220	241	265	275	297	308	266	204	248	260	272
TTM Operating Income	63	69	87	130	164	178	198	204	220	225	185	133	178	188	191
TTM Cash Flow to Firm	80	89	113	149	199	216	241	254	294	282	259	228	240	264	291
TTM Free Cash Flow to Firm	155	89	113	149	199	216	241	254	294	282	259	228	244	268	291

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	8.01	18.24	15.29	18.53	13.94	16.44	15.66	15.3	14.78	13.31	12.46	12.62	12.88	14.43	15.19
EV/EBIT	21.9	26.6	25.58	24.91	19.65	22.65	21.47	21.83	22.65	20.31	20.74	26.26	19.92	22.17	24.88
Enterprise Value	1,386	1,841	2,230	3,226	3,221	4,026	4,246	4,456	4,984	4,569	3,843	3,486	3,556	4,179	4,742
Low Price	37.9	43.37	53.01	54.75	53.64	54.51	68.96	62.71	73.35	31.37	50.88	50.22	47.54	51.59	65.13
EV/Sales	16.56	19.73	18.93	18.17	14.07	16.21	15.24	15.13	15.67	13.73	12.86	12.53	11.12	12.47	12.63
EV/EBITDA	18.27	21.28	20.63	18.95	14.61	16.72	16.02	16.18	16.79	14.83	14.44	17.12	14.31	16.08	17.47
Price/Earnings	15.03	17.33	14.98	22.98	15.38	19.09	19.34	20.53	22.05	16.7	23.5	35.21	17.86	22.02	25.18
Price/Earnings Average	15.35	15.6	16.53	20.48	16.34	18.26	19.55	19.76	21.68	15.45	26.27	39.07	16.9	21.79	24.36
Price/Earnings High	16.93	17.56	19.5	23.57	19.45	21.25	20.94	22.17	23.42	22	32.12	45.29	19.25	27.37	26.56
Price/Earnings Low	12.95	13.29	14.16	17.98	13.55	14.03	17.7	17.04	19.85	7.57	20.8	33.86	15.21	16.39	21.47
Price/Book Value	-41.5	-86.31	471.73	-12,035.99	113.06	95.59	93.36	171.31	-724.19	-143.38	-31.24	1	0.98	1.17	1.3
Price/Book Value Average	-42.4	-77.71	520.26	-10,725.2	120.14	91.39	94.37	164.89	-712.18	-132.62	-34.93	1.11	0.93	1.15	1.26
Price/Book Value High	-46.76	-87.48	613.75	-12,343.95	142.98	106.37	101.06	184.97	-769.17	-188.88	-42.7	1.29	1.06	1.45	1.37
Price/Book Value Low	-35.76	-66.22	445.74	-9,419.25	99.63	70.25	85.4	142.22	-651.93	-65.02	-27.66	0.96	0.84	0.87	1.11
Price/Tangible Book Value	2.75	3.36	2.05	2.22	2	2.39	2.33	2.28	2.36	2.03	1.73	1.81	1.9	2.19	2.32
Price/Tangible Book Value Average	2.81	3.02	2.26	1.98	2.13	2.29	2.36	2.19	2.32	1.88	1.94	2.01	1.8	2.17	2.25
Price/Tangible Book Value High	3.1	3.4	2.66	2.28	2.53	2.66	2.52	2.46	2.51	2.67	2.37	2.33	2.05	2.73	2.45
Price/Tangible Book Value Low	2.37	2.58	1.93	1.74	1.77	1.76	2.13	1.89	2.13	0.92	1.53	1.74	1.62	1.63	1.98
Price/Sales	14.56	16.85	13.5	13.15	10	11.65	11.06	10.75	11.12	9.29	8.79	8.4	7.58	9.07	9.53
Price/Sales Average	14.87	15.17	14.89	11.72	10.62	11.13	11.18	10.35	10.94	8.59	9.83	9.33	7.17	8.97	9.22
Price/Sales High	16.4	17.08	17.57	13.49	12.64	12.96	11.98	11.61	11.81	12.24	12.02	10.81	8.16	11.27	10.05
Price/Sales Low	12.55	12.93	12.76	10.29	8.81	8.56	10.12	8.93	10.01	4.21	7.79	8.08	6.45	6.75	8.13
Price/Cash Flow	15.86	18.23	15.27	18.51	13.92	16.38	15.56	15.24	14.68	13.32	12.46	12.62	13.14	14.62	15.13
Price/Cash Flow Average	16.2	16.41	16.84	16.49	14.79	15.66	15.73	14.67	14.44	12.32	13.93	14	12.43	14.47	14.64
Price/Cash Flow High	17.87	18.47	19.87	18.98	17.61	18.23	16.85	16.46	15.59	17.54	17.03	16.22	14.15	18.18	15.96
Price/Cash Flow Low	13.67	13.98	14.43	14.49	12.27	12.04	14.24	12.65	13.22	6.04	11.03	12.13	11.18	10.89	12.91
Price/Free Cash Flow Average	8.18	16.43	16.86	16.51	14.81	15.72	15.83	14.72	14.53	12.31	13.93	14.01	12.18	14.28	14.69
Price/Free Cash Flow High	9.02	18.49	19.89	19.01	17.62	18.29	16.95	16.52	15.7	17.53	17.03	16.23	13.87	17.93	16.02
Price/Free Cash Flow Low	6.9	14	14.45	14.5	12.28	12.08	14.33	12.7	13.3	6.04	11.03	12.14	10.96	10.74	12.95
EV/Sales Average	17.01	18.05	20.32	16.74	14.69	15.69	15.36	14.72	15.49	13.03	13.9	13.45	10.71	12.37	12.31
EV/Sales High	18.54	19.96	22.99	18.51	16.71	17.52	16.15	15.98	16.36	16.68	16.09	14.94	11.7	14.67	13.15
EV/Sales Low	14.68	15.81	18.18	15.31	12.88	13.12	14.3	13.3	14.56	8.65	11.86	12.21	9.99	10.15	11.22
EV/EBITDA Average	18.77	19.47	22.14	17.46	15.26	16.19	16.15	15.74	16.59	14.08	15.61	18.38	13.79	15.95	17.03
EV/EBITDA High	20.46	21.53	25.06	19.31	17.36	18.07	16.98	17.09	17.53	18.02	18.07	20.4	15.07	18.92	18.19
EV/EBITDA Low	16.2	17.05	19.82	15.97	13.38	13.53	15.03	14.22	15.6	9.35	13.31	16.68	12.86	13.09	15.52
EV/EBIT Average	22.49	24.34	27.45	22.95	20.53	21.94	21.64	21.25	22.39	19.28	22.42	28.19	19.19	22	24.27
EV/EBIT High	24.52	26.91	31.07	25.37	23.35	24.49	22.75	23.07	23.65	24.68	25.95	31.3	20.97	26.08	25.91
EV/EBIT Low	19.42	21.31	24.57	20.99	18	18.34	20.14	19.19	21.05	12.8	19.12	25.58	17.9	18.05	22.12
Last Price	43.98	56.53	56.1	69.96	60.87	74.17	75.38	75.54	81.48	69.17	57.47	52.22	55.85	69.3	76.37
High Price	49.55	57.3	72.99	71.75	76.98	82.53	81.6	81.56	86.54	91.12	78.56	67.16	60.17	86.13	80.56
Enterprise Value Average	1,424	1,685	2,394	2,972	3,364	3,899	4,280	4,337	4,926	4,337	4,153	3,743	3,425	4,147	4,626
Enterprise Value High	1,552	1,863	2,709	3,286	3,826	4,352	4,501	4,709	5,204	5,550	4,807	4,155	3,744	4,917	4,939
Enterprise Value Low	1,229	1,475	2,143	2,718	2,949	3,259	3,984	3,918	4,631	2,879	3,541	3,396	3,196	3,402	4,215

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	28	28	33	37	38	40	42	43	45	45	46	43	43	46	48
Diluted Weighted Avg Shares	28	28	28	33	38	39	41	42	44	45	46	45	43	44	47
Basic Weighted Avg Shares	28	28	28	33	38	39	41	42	43	45	46	45	43	44	47
Revenue per Share	3.02	3.36	4.15	5.32	6.09	6.37	6.81	7.02	7.33	7.45	6.53	6.21	7.37	7.64	8.01
EBITDA per Share	2.74	3.11	3.81	5.1	5.86	6.17	6.48	6.57	6.84	6.89	5.82	4.55	5.73	5.93	5.79
Operating Income per Share	2.28	2.49	3.07	3.88	4.36	4.56	4.84	4.87	5.07	5.03	4.05	2.97	4.11	4.3	4.07
Basic EPS, GAAP	2.93	3.26	3.74	3.04	3.96	3.88	3.9	3.68	3.7	4.14	2.45	1.48	3.13	3.15	3.03
Basic EPS from Cont Ops	2.52	2.62	2.8	3.09	4	3.91	3.9	3.68	3.7	4.15	2.45	1.46	3.1	3.12	3
Diluted EPS, GAAP	2.92	3.26	3.74	3.04	3.95	3.87	3.87	3.67	3.67	4.14	2.44	1.48	3.13	3.13	3.02
Diluted EPS from Cont Ops	2.51	2.62	2.8	3.08	3.99	3.9	3.87	3.67	3.67	4.15	2.45	1.46	3.1	3.1	2.99
Dividend per Share	2.45	2.84	3	3.02	3.31	3.55	3.74	3.94	4.14	4.35	4	3.61	3.6	3.57	3.62
Cash Flow per Share	2.77	3.1	3.67	3.78	4.37	4.53	4.84	4.96	5.55	5.19	4.61	4.14	4.25	4.74	5.05
Free Cash Flow per Basic Share	0.04	3.1	3.67	3.78	4.37	4.53	4.84	4.96	5.55	5.19	4.61	4.14	4.16	4.65	5.05
Cash & Equivalents per Share	0.98	0.33	0.4	0.1	0.35	0.12	0.07	0.11	0.12	0.97	0.82	0.43	0.52	0.55	0.42
Book Value per Share	-1.06	-0.65	0.12	-0.01	0.54	0.78	0.81	0.44	-0.11	-0.48	-1.84	52.07	56.86	59.42	58.61
Tangible Book Value per Share	16	16.83	27.4	31.46	30.38	31	32.33	33.13	34.51	34.07	33.18	28.81	29.36	31.59	32.85

National Health Investors, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)